Rachel Haurwitz's most recent trade in Caribou Biosciences Inc was a trade of 20,000 Common Stock done at an average price of $1.0 . Disclosure was reported to the exchange on March 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 14 Mar 2025 | 20,000 | 3,369,395 | - | 1.0 | 20,400 | Common Stock |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 618,250 | 618,250 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 136,750 | 295,450 | - | 0 | Common Stock | |
| Seer Inc - Ordinary Shares... | Rachel Haurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 58,178 | 87,615 | - | 0 | Class A Common Stock | |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 546,950 | 546,950 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Haurwitz Rachel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 118,700 | 158,700 | - | 0 | Common Stock | |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.96 per share. | 20 Mar 2023 | 10,000 | 30,000 | - | 3.0 | 29,600 | Common Stock |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2023 | 10,000 | 106,350 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 510,500 | 510,500 | - | - | Option to purchase Common Stock | |
| Seer Inc - Ordinary Shares... | Rachel Haurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 17,865 | 17,865 | - | - | Stock Option (right to buy) | |
| Seer Inc - Ordinary Shares... | Rachel Haurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 5,994 | 5,994 | - | 0 | Class A Common Stock | |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.96 per share. | 09 May 2022 | 10,000 | 20,000 | - | 3.0 | 29,600 | Common Stock |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 10,000 | 116,350 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2022 | 10,000 | 126,350 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.96 per share. | 26 Jan 2022 | 10,000 | 10,000 | - | 3.0 | 29,600 | Common Stock |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 411,000 | 411,000 | - | - | Option to purchase Common Stock |